Mixing insulin aspart with detemir does not affect glucose excursion in children with type 1 diabetes

Thanh M Nguyen, Venkat S Renukuntla, Rubina A Heptulla, Thanh M Nguyen, Venkat S Renukuntla, Rubina A Heptulla

Abstract

Objective: We hypothesized that insulin detemir mixed with aspart had equivalent effects on blood glucose as if being given as separate injections in pediatric type 1 diabetes patients.

Research design and methods: Fourteen children with type 1 diabetes were randomly assigned to either Study A (mixed insulins) or Study B (separate insulins) for the first 10 days and crossed over for the last 10 days. Each subject underwent continuous glucose monitoring on the last 72 h of each study.

Results: The 48-h area under the curve (mmol/hour/l), M-value, and mean amplitude of glucose excursion (mmol/l) for Study A versus Study B were 457 +/- 70 versus 469 +/- 112 (P = 0.58), 39.67 +/- 15.37 versus 39.75 +/- 9.69 (P = 0.98), and 6.35 +/- 1.92 versus 5.98 +/- 0.92 (P = 0.42), respectively.

Conclusions: Insulin detemir mixed with aspart had equivalent effects on blood glucose versus giving them as separate injections in children with type 1 diabetes.

Figures

Figure 1
Figure 1
The 48-h CGM tracings for each subject taking detemir separately from aspart (gray lines) and detemir mixed with aspart (black lines).

References

    1. Martin D, Licha-Müntz G, Grasset E, Grenèche MO, Nouet D, François L, Legrand C, Polak M, Augendre-Ferrante B, Tubiana-Rufi N, Robert JJ. Efficacy of Humalog injections before an afternoon meal and their acceptance by children and adolescents with type 1 diabetes. Diabet Med 2002;19:1026–1031
    1. Johns C, Faulkner MS, Quinn L. Characteristics of adolescents with type 1 diabetes who exhibit adverse outcomes. Diabetes Educ 2008;34:874–885
    1. Kaplan W, Rodriguez LM, Smith OE, Haymond MW, Heptulla RA. Effects of mixing glargine and short-acting insulin analogs on glucose control. Diabetes Care 2004;27:2739–2740
    1. Fiallo-Scharer R, Horner B, McFann K, Walravens P, Chase HP. Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus. J Pediatr 2006;148:481–484
    1. Cengiz E, Tamborlane WV, Martin-Fredericksen M, Dziura J, Weinzimer SA. Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes. Diabetes Care 2010;33:1009–1012
    1. Schlichtkrull J, Munck O, Jersild M. The M-value, an index of blood-sugar control in diabetics. Acta Med Scand 1965;177:95–102
    1. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644–655

Source: PubMed

3
Předplatit